Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,162 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[Certolizumab].
Charles J; Groupe de recherche sur le psoriasis de la Société française de dermatologie. Charles J, et al. Ann Dermatol Venereol. 2019 Jun-Jul;146(6-7):487-491. doi: 10.1016/j.annder.2019.04.004. Epub 2019 Jun 14. Ann Dermatol Venereol. 2019. PMID: 31208736 French. No abstract available.
[Acantholytic dermatosis in patients treated by vemurafenib: 2 cases].
Sabatier-Vincent M, Charles J, Pinel N, Challende I, Claeys A, Leccia MT. Sabatier-Vincent M, et al. Among authors: charles j. Ann Dermatol Venereol. 2014 Nov;141(11):689-93. doi: 10.1016/j.annder.2014.09.024. Epub 2014 Oct 23. Ann Dermatol Venereol. 2014. PMID: 25442474 French.
[Digital ischaemia with fingertip ulcers during ipilimumab therapy].
Zenati N, Charles J, Templier I, Blaise S. Zenati N, et al. Among authors: charles j. Ann Dermatol Venereol. 2020 Mar;147(3):212-216. doi: 10.1016/j.annder.2019.09.606. Epub 2019 Dec 18. Ann Dermatol Venereol. 2020. PMID: 31864764 French.
[Mechanisms of resistance to anti-BRAF treatments].
Charles J, Martel C, de Fraipont F, Leccia MT, Robert C, Busser B. Charles J, et al. Ann Dermatol Venereol. 2014 Nov;141(11):671-81. doi: 10.1016/j.annder.2014.06.021. Epub 2014 Aug 7. Ann Dermatol Venereol. 2014. PMID: 25442471 Review. French.
[Treatment of patients with inoperable stage III or stage IV melanoma. Société française de dermatologie].
Guillot B, Charles J, Jeudy G, Cupissol D, Dupuy A, Dutriaux C, Gangloff D, Magne N, Mirabel X, M'Sadek A, Pracht M, Sichel C, Do Outeiro G. Guillot B, et al. Among authors: charles j. Ann Dermatol Venereol. 2018 Jun-Jul;145(6-7):413-422. doi: 10.1016/j.annder.2018.03.165. Epub 2018 Apr 25. Ann Dermatol Venereol. 2018. PMID: 29703640 French. No abstract available.
T-cell receptor diversity as a prognostic biomarker in melanoma patients.
Charles J, Mouret S, Challende I, Leccia MT, De Fraipont F, Perez S, Plantier N, Plumas J, Manuel M, Chaperot L, Aspord C. Charles J, et al. Pigment Cell Melanoma Res. 2020 Jul;33(4):612-624. doi: 10.1111/pcmr.12866. Epub 2020 Feb 3. Pigment Cell Melanoma Res. 2020. PMID: 31971658
An innovative plasmacytoid dendritic cell line-based cancer vaccine primes and expands antitumor T-cells in melanoma patients in a first-in-human trial.
Charles J, Chaperot L, Hannani D, Bruder Costa J, Templier I, Trabelsi S, Gil H, Moisan A, Persoons V, Hegelhofer H, Schir E, Quesada JL, Mendoza C, Aspord C, Manches O, Coulie PG, Khammari A, Dreno B, Leccia MT, Plumas J. Charles J, et al. Oncoimmunology. 2020 Apr 12;9(1):1738812. doi: 10.1080/2162402X.2020.1738812. eCollection 2020. Oncoimmunology. 2020. PMID: 32313721 Free PMC article. Clinical Trial.
1,162 results